Financhill
Back

PIMCO Municipal Income Fund III Vs. MoonLake Immunotherapeutics Industry Stock Comparison

Sell
32

PMX
PIMCO Municipal Income Fund III

Last Price:
$6.83
Seasonality Move:
-1.01%
Buy
64

MLTX
MoonLake Immunotherapeutics

Last Price:
$48.33
Seasonality Move:
19.44%
Sell
32
PIMCO Municipal Income Fund III (PMX) is a Sell

Is PIMCO Municipal Income Fund III a Buy, Sell or Hold?

  • The current PIMCO Municipal Income Fund III [PMX] share price is $6.84. The Score for PMX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • PMX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
MoonLake Immunotherapeutics (MLTX) is a Buy

Is MoonLake Immunotherapeutics a Buy, Sell or Hold?

  • The current MoonLake Immunotherapeutics [MLTX] share price is $48.28. The Score for MLTX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • MLTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PMX Stock Price Chart

What is PIMCO Municipal Income Fund III's stock price today?

  • The PIMCO Municipal Income Fund III share price today is $6.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PMX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MLTX Stock Price Chart

What is MoonLake Immunotherapeutics's stock price today?

  • The MoonLake Immunotherapeutics share price today is $48.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight buying pressure.

PMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.97 Buy
Relative Strength Index (14 RSI): 53.23 Buy
Chaikin Money Flow: 40536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.76 - 6.84) Buy
Bollinger Bands (100): (6.72 - 7.26) Sell

MLTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.73 Buy
Relative Strength Index (14 RSI): 60.93 Buy
Chaikin Money Flow: 289444 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.29 - 48.45) Buy
Bollinger Bands (100): (37.35 - 44.83) Buy

PMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.85 Sell
20-day SMA: 6.8 Buy
50-day SMA: 6.84 Sell
200-day SMA: 7.37 Sell
8-day EMA: 2.7 Buy
20-day EMA: 1.24 Buy
50-day EMA: 0.53 Buy
200-day EMA: 0.14 Buy

MLTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.58 Buy
20-day SMA: 45.86 Buy
50-day SMA: 42.87 Buy
200-day SMA: 45.55 Buy
8-day EMA: 18.81 Buy
20-day EMA: 8.63 Buy
50-day EMA: 3.65 Buy
200-day EMA: 0.94 Buy

PIMCO Municipal Income Fund III Earnings Growth & PMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.

PIMCO Municipal Income Fund III Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MoonLake Immunotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):